Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the Clinical Utility and Cost Effectiveness Ratio of Generalized Neonatal Screening for Severe Combined Immunodeficiencies (SCID) by Quantification of TRECs on Guthrie Cards

NCT02244450 is registered in ClinicalTrials.gov with Nantes University Hospital as lead sponsor.

NCT NCT02244450
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02244450 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the Clinical Utility and Cost Effectiveness Ratio of Generalized Neonatal Screening for Severe Combined Immunodeficiencies (SCID) by Quantification of TRECs on Guthrie Cards
Lead sponsor
Nantes University Hospital
Phase
Not applicable
Overall status
Completed
Start date
December 31, 2014
Completion date
April 28, 2018
Enrollment
190,539 (actual)
Sites
51

Conditions

As the registry lists them; a condition with its own page is linked.

severe combined immunodeficiency, atypical